C. Lindsay DeVane, Pharm.D.  Dr. DeVane is Professor of Psychiatry and Behavioral Sciences and Director, Laboratory of Drug Disposition and Pharmacogenetics at the Medical University of South Carolina, Charleston.  His research interests include mechanisms and effects of drug interactions, placental and blood brain barrier transport of psychoactive drugs and the effects of age and disease states on drug/metabolite disposition.  Dr. DeVane serves on several editorial boards of scientific journals, including clinical Pharmacology and Therapeutics and Clinical Pharmacokinetics, and is the author or co-author on over 240 scientific publications.

K. Ranga Rama Krishnan, M.D.  Dr. Krishnan is Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, North Carolina.  Dr. Krishnan was the Chair of the Clinical Neuroscience and Biological Psychopathology Review Committee of the National Institute of Mental Health.  He has been listed in Marquis' Who's Who in Science and Engineering and received the National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award for Genetic Imaging Study in Bipolar Disorder.  A member of several professional societies, including the American Psychiatric Association and the International Association for the Study of Pain, Dr. Krishnan serves and has served on the editorial boards of such scientific journals as American Journal of Psychiatry, Biological Psychiatry, and Psychiatric Research: Neuroimaging.  Dr. Krishnan's work has been widely published in numerous scientific journals and books. His current research interests include treatment of depression in coronary heart disease, neuroimaging, and bipolar disorder in late life.

Charles B. Nemeroff, M.D.,Ph.D.  Dr. Nemeroff has been the Reunette W. Harris Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia since 1991.  He is past President of the American College of Psychiatrists and the American College of Neuropsychopharmacology.  He is Editor-in-Chief of Neuropsychopharmacology.  Dr. Nemeroff serves on the scientific advisory board of numerous pharmaceutical companies including Acadia, Abbott, Forest Laboratories, Janssen, Pfizer, Organon, GlaxoSmithKline and Wyeth-Ayerst and also serves on NovaDel’s Board of Directors.  Dr. Nemeroff has received numerous awards for his research, including the Bowis Award from the American College of Psychiatrists and the Menninger Prize from the American College of Physicians.  In 2002 he was elected to the Institute of Medicine.

Allan Levey, M.D.,Ph.D.  Dr. Levey currently serves as Professor of Neurology, Pharmacology and Psychiatry and Chairman, Department of Neurology at Emory University, Atlanta, Georgia.  His research interests include the molecular pharmacology of neurological diseases, and clinical and basic research in neurodegenerative diseases, especially Alzheimer's and Parkinson's disease.  He is author to numerous publications.  Honors include the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association, Heikkila Research Scholar Award from the National Parkinson Foundation, ISI Highly Cited Researcher, Neuroscience, and Health Advancement Research Award, Community Health Charities.

Stephen Stahl, M.D.,Ph.D.  Dr. Stahl is Adjunct Professor of Psychiatry, University of California San Diego and Chairman of the Neuroscience Education Institute, a medical education company dedicated to producing and disseminating information about diseases in psychiatry and neurology and their treatments, with a special emphasis on multimedia, the Internet, and teaching how to teach.  Dr. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, his Ph.D. in Pharmacology from the University of Chicago, and his clinical training in internal medicine from the University of Chicago, in neurology from the University of California in San Francisco, and in psychiatry from Stanford University.  Author of more than 300 articles and chapters, Dr. Stahl is an internationally recognized clinician, researcher, and teacher in psychopharmacology.  He has edited two books and written three others, including the best-selling textbook Essential Psychopharmacology. Dr. Stahl also writes a highly popular monthly feature for mental health professionals, know as "Brainstorms," for the Journal of Clinical Psychiatry.  He serves as a counselor for the CINP, on numerous editorial boards for journals, and on advisory boards for pharmaceutical, biotechnology, and medical information companies as well as for non-profit and public service organizations.